LAM launches wound gel in Latin America:
This article was originally published in Clinica
Executive Summary
Transdermal drug delivery systems specialist LAM Pharmaceutical today announced the launch of its IPM Wound Gel. Distributors and healthcare professionals from Argentina, Brazil, Costa Rica, Ecuador, El Salvador and Panama have expressed an interest in the gel, claims the Lewiston, New York-based company. It features LAM's Ionic Polymer Matrix (IPM) technology - "a combination of electrically charged and non-charged molecules with wound-healing properties". LAM has offices in Canada (Toronto) and China (Beijing).
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.